Ulta Beauty
ULTA
$479.87
-2.92%
Ulta Beauty is the largest specialized beauty retailer in the United States, operating over 1,500 freestanding stores that offer a comprehensive assortment of cosmetics, fragrances, skin care, and hair care products, complemented by in-store salon services. The company has established a distinct competitive identity as a one-stop destination that successfully blends mass and prestige brands, creating a unique omnichannel experience that drives customer loyalty and traffic. The current investor narrative is dominated by concerns over margin pressure and rising costs, as evidenced by the stock's sharp decline following its Q4 2024 earnings report, which overshadowed revenue and profit beats and has sparked a debate about the company's ability to navigate an inflationary environment while sustaining growth.…
ULTA
Ulta Beauty
$479.87
Related headlines
Investment Opinion: Should I buy ULTA Today?
Rating: HOLD. The core thesis is that while Ulta's strong business model and cash flow provide a floor, near-term margin uncertainty and technical damage warrant caution, making the stock a 'show me' story rather than a clear buy.
Supporting Evidence: 1) The forward P/E of 15.61x is reasonable for a market leader with a 41.14% ROE, implying earnings growth recovery. 2) Revenue growth remains positive at 11.78% YoY. 3) The balance sheet is strong with a 0.78 Debt/Equity ratio and $985.6M in FCF. 4) However, severe margin compression (gross margin down 106 bps YoY) and a 27.67% 3-month price decline demonstrate significant near-term headwinds that offset the valuation appeal.
Risks & Conditions: The two biggest risks are further margin deterioration and a breakdown below the $402.5 technical support. This Hold would upgrade to a Buy if Q1 2025 results show gross margin stabilization above 38% and the stock holds above $480 support, confirming a bottom. It would downgrade to a Sell if gross margin falls below 37% or the stock breaks below $400. The stock is currently fairly valued relative to its near-term challenges but undervalued relative to its long-term earnings power if margins recover.
Sign up to view all
ULTA 12-Month Price Forecast
The outlook is balanced with a slight tilt to caution. The compelling forward valuation and financial strength are counteracted by clear and present margin pressures and broken price momentum. The base case of range-bound trading is most likely, as the market awaits concrete evidence of margin stabilization. The stance would upgrade to Bullish on confirmation of gross margin bottoming (e.g., two consecutive quarters of sequential improvement) and would downgrade to Bearish on a breakdown below the $400 support level on worsening fundamentals.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Ulta Beauty's 12-month outlook, with a consensus price target around $623.83 and implied upside of +30.0% versus the current price.
Average Target
$623.83
5 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
5
covering this stock
Price Range
$384 - $624
Analyst target range
Analyst coverage appears limited with only 5 analysts providing estimates, which suggests the stock may have less institutional scrutiny typical of a mid-cap company, potentially leading to higher volatility. The consensus sentiment leans bullish among the broader institutional firms, with recent ratings from Morgan Stanley, JP Morgan, and Piper Sandler all at 'Overweight' or equivalent, and firms like Wells Fargo maintaining an 'Underweight' stance, indicating a divided but generally positive view. The target price range implied by earnings estimates is wide, with a low EPS estimate of $42.52 and a high of $44.26, translating to a significant spread that reflects high uncertainty about the company's near-term earnings trajectory and the impact of margin pressures, with the high target likely pricing in a successful cost management and growth rebound story.
Bulls vs Bears: ULTA Investment Factors
The bear case currently holds stronger evidence, primarily driven by the severe and ongoing margin compression that has triggered a sharp technical breakdown and overshadowed solid revenue growth. The most critical tension in the investment debate is whether management can successfully navigate inflationary cost pressures to stabilize and eventually expand margins, or if the current compression represents a structural shift that permanently impairs profitability. If margins stabilize, the attractive forward valuation and strong cash flow could drive a significant rebound. If they continue to deteriorate, the elevated trailing multiple and growth deceleration could lead to further downside.
Bullish
- Strong Financial Health & Cash Flow: Ulta maintains a robust balance sheet with a healthy current ratio of 1.41 and a manageable debt-to-equity ratio of 0.78. The company generates substantial free cash flow of $985.6M TTM, funding operations and growth internally without reliance on external financing.
- Attractive Forward Valuation: The stock's forward P/E of 15.61x represents a significant discount to its trailing P/E of 25.17x, indicating the market expects a strong earnings recovery. This forward multiple is more reasonable given the company's market-leading position and high ROE of 41.14%.
- Resilient Revenue Growth: Despite deceleration, Q4 2024 revenue grew 11.78% YoY to $3.90B, demonstrating continued consumer demand. The company's unique mass-and-prestige model and omnichannel experience drive customer loyalty in a defensive beauty category.
- High Short Interest Could Fuel Squeeze: A short ratio of 3.26 indicates elevated bearish sentiment. Combined with the stock trading near its 52-week low, any positive catalyst regarding margin stabilization could trigger a significant short squeeze, amplifying upside moves.
Bearish
- Severe Margin Compression: Gross margin compressed 106 bps YoY to 38.06% in Q4 2024, while net margin fell 213 bps to 9.15%. This pressure, driven by rising costs and inflation, is the core investor concern that triggered the recent 27.67% 3-month stock decline.
- Technical Downtrend & Underperformance: The stock is in a pronounced downtrend, down 27.67% over 3 months and underperforming the S&P 500 by 36.09 percentage points. Trading at $494.28, it sits just 25% above its 52-week low, indicating persistent selling pressure and broken momentum.
- Revenue Growth Deceleration: While Q4 revenue grew 11.78% YoY, this marks a slowdown from stronger prior quarters. This normalization raises questions about the sustainability of growth, especially if consumer spending weakens in a potential stagflationary environment.
- Elevated Trailing Valuation vs. Peers: Ulta's trailing P/E of 25.17x trades at a premium to the sector average. This premium is vulnerable to further compression if margin pressures persist and earnings growth fails to meet the forward P/E's implied expectations.
ULTA Technical Analysis
The stock is in a pronounced downtrend, having declined 27.67% over the past three months and 8.32% over the past month, which starkly contrasts with its positive 20.05% gain over the past year, indicating a significant recent breakdown. Currently trading at $494.28, the price sits just 25% above its 52-week low of $402.5 and 31% below its 52-week high of $714.97, positioning it near the lower end of its annual range and suggesting it is approaching oversold territory but remains vulnerable to further selling pressure. Recent momentum is decisively negative and diverging from the longer-term uptrend, with the 1-month decline of 8.32% and 3-month drop of 27.67% signaling a potential trend reversal or a deep correction, exacerbated by severe underperformance relative to the S&P 500, which gained 5.6% and 8.42% over the same periods, respectively. Key technical support is clearly defined at the 52-week low of $402.5, while major resistance lies at the recent high near $714.97; a sustained breakdown below support could trigger another leg down, whereas a recovery above the $600 level would be needed to signal a reversal. The stock's beta of 0.891 indicates it is slightly less volatile than the broader market, which, combined with a short ratio of 3.26, suggests elevated bearish sentiment that could fuel a sharp squeeze on any positive catalyst.
Beta
0.89
0.89x market volatility
Max Drawdown
-32.1%
Largest decline past year
52-Week Range
$403-$715
Price range past year
Annual Return
+16.2%
Cumulative gain past year
| Period | ULTA Return | S&P 500 |
|---|---|---|
| 1m | -13.3% | +4.0% |
| 3m | -32.1% | +8.2% |
| 6m | -3.5% | +11.5% |
| 1y | +16.2% | +24.3% |
| ytd | -22.6% | +8.3% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
ULTA Fundamental Analysis
Revenue growth remains positive but shows signs of deceleration; the most recent quarterly revenue for Q4 2024 (ended Jan 31, 2026) was $3.90 billion, representing a solid 11.78% year-over-year increase, yet this marks a slowdown from the stronger growth rates seen in prior quarters, indicating a normalization in consumer demand. The company is profitable with a net income of $356.68 million in Q4 2024, but profitability metrics are under pressure, as evidenced by a gross margin of 38.06% for the quarter, which has compressed from 39.12% in the year-ago period, and a net margin of 9.15%, down from 11.28% a year ago, reflecting rising cost pressures. The balance sheet is healthy with a current ratio of 1.41 and a manageable debt-to-equity ratio of 0.78, while the company generates robust cash flow, with trailing twelve-month free cash flow of $985.56 million and an impressive return on equity of 41.14%, indicating strong financial health and efficient use of shareholder capital to fund operations and growth internally.
Quarterly Revenue
$3.9B
2026-01
Revenue YoY Growth
+0.11%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$985555000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is ULTA Overvalued?
Given the company's consistent profitability with positive net income, the primary valuation metric selected is the Price-to-Earnings (PE) ratio. The trailing PE stands at 25.17x, while the forward PE is significantly lower at 15.61x, indicating the market expects a substantial recovery in earnings growth over the next twelve months. Compared to sector averages, Ulta's trailing PE of 25.17x trades at a premium; however, this premium must be contextualized by its superior return on equity of 41.14% and its market-leading position, which may justify a higher multiple if growth re-accelerates. Historically, the current trailing PE of 25.17x is below the stock's own recent peak multiples seen in early 2025 (e.g., 25.18x in Q3 2025) but remains elevated compared to its lows near 12.12x in early 2024, suggesting the valuation is moderating from optimistic levels but is not yet at a deep value point, reflecting ongoing uncertainty about future earnings power.
PE
25.2x
Latest Quarter
vs. Historical
High-End
5-Year PE Range 12x~25x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
16.6x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks center on profitability erosion. Gross margin fell from 39.12% to 38.06% YoY in Q4, and net margin dropped from 11.28% to 9.15%. This 213 bps net margin compression, if annualized on estimated revenue of $16.3B, represents a potential ~$350M headwind to net income. The company's valuation (25.17x trailing P/E) is highly dependent on reversing this trend; failure to do so would severely impact earnings multiples. Revenue concentration in the cyclical U.S. consumer discretionary sector adds sensitivity to economic downturns.
Market & Competitive Risks include valuation compression given the stock's premium trailing P/E relative to the sector. The recent news highlights stagflation fears, a worst-case macro scenario for retailers facing rising costs and slowing demand. Ulta's beta of 0.891 suggests less volatility than the market, but the 27.67% 3-month drop shows high company-specific risk. Competitive risks are heightened as consumers may trade down within the beauty category, and Ulta's unique model faces pressure from both mass merchants and premium brands going direct-to-consumer.
The Worst-Case Scenario involves a stagflationary environment where persistent inflation keeps costs high while slowing GDP growth reduces consumer spending on discretionary beauty. This leads to further margin compression and revenue growth stalling below 5%. Analyst EPS estimates are cut towards the low end of $42.52, and the P/E multiple re-rates towards its historical low near 12x. This could drive the stock to retest and break its 52-week low of $402.5, implying a potential loss of approximately -35% from the current price of $494.28.
FAQ
The primary risk is further margin compression (gross margin already down 106 bps YoY), which directly threatens earnings and the valuation multiple. Second is a consumer slowdown, which could decelerate revenue growth from its current 11.78% pace. Third is competitive and operational risk, including the end of the Target partnership in 2026. Fourth is technical risk, with the stock in a downtrend and near its 52-week low, susceptible to further selling pressure.
Our 12-month forecast outlines three scenarios. The Base Case (55% probability) sees the stock trading between $500 and $600 as margin pressures moderate. The Bull Case (25%) targets $650-$715 on successful margin stabilization and renewed growth. The Bear Case (20%) warns of a drop to $402-$480 if stagflation hits and margins worsen further. The Base Case is most likely, implying limited near-term upside until fundamental trends clarify.
ULTA is fairly valued relative to its near-term challenges but potentially undervalued on a longer-term basis. The trailing P/E of 25.17x is elevated versus peers, reflecting past optimism. However, the forward P/E of 15.61x prices in a significant earnings recovery, which seems reasonable for a company with a 41.14% ROE. The market is currently paying a fair price for uncertainty; the stock is not cheap enough to ignore the risks, nor expensive if the recovery materializes.
ULTA is a Hold, not a clear Buy at this moment. For investors with a long-term horizon and high risk tolerance, the forward P/E of 15.6x and strong cash flow offer value if you believe margins will recover. However, the severe 27.67% 3-month decline and ongoing margin pressure make timing difficult. It could be a good buy for patient investors on further weakness towards $450, but aggressive buying here is premature until margin trends improve.
ULTA is more suitable for a long-term investment horizon of 3+ years. The current issues are cyclical (margin pressure) rather than structural, and the company's strong market position and cash flow can support it through a downturn. Its beta of 0.891 suggests lower volatility than the market, but the recent crash shows high company-specific risk, making it poor for short-term trading. The lack of a dividend also means returns are solely dependent on price appreciation, which requires patience for the thesis to play out.
